Clinical Trials
As an infrastructure at the German Center for Infection Research (DZIF), the Clinical Trial Unit tracks DZIF's study activities in the “Healex Site Management System (SMS)”. Studies are sorted by indication and are continuously updated.
The study register has recently been expanded to include the category “COVID-19”. For the first time, not only DZIF study activities are presented here: In order to provide a comprehensive overview in the current pandemic situation of planned and already active COVID-19 studies in Germany, the Clinical Trial Unit is cooperating with researchers from various German Centers for Health Research and other networks.
For researchers: If your study is not yet included in our portal, please contact the project management of the Clinical Trial Unit.
COVID-19 Hydroxychloroquine for COVID-19
- Overall study
- Study Sites (5)
Balingen
Zollernalb Klinikum Balingen
Address
Tübinger Str. 30, 72336 Balingen
Status
Active
Principal Investigator
PD Dr. Dr. Erwin Biecker
Hamburg
Universitätsklinikum Hamburg-Eppendorf
Address
Martinistraße 52
20251 Hamburg
Status
Active
Principal Investigator
Prof. Dr. med. Marylyn M. Addo
Reutlingen
Klinikum am Steinenberg (Kreiskliniken Reutlingen)
Address
Kreiskliniken Reutlingen GmbH,
Klinikum am Steinenberg,
Steinenbergweg 31,
72764 Reutlingen
Status
Active
Principal Investigator
PD Dr. med. Stefan Kubicka
Stuttgart
Robert-Bosch Krankenhaus Stuttgart
Address
Auerbachstraße 110
70376 Stuttgart
Status
Active
Principal Investigator
Prof. Dr. med. Matthias Schwab
Tübingen
DZIF-CTU Tübingen
Address
Universitätsklinikum Tübingen, Institut für Tropenmedizin
Wilhelmstrasse 27
72074 Tübingen
Germany
Study office
Institut für Tropenmedizin Tübingen
- Tel. +497071 2982191
- Fax +497071 294684
Status
Active
Principal Investigator
Prof. Dr. med. Peter Kremsner